Search results
Neonate, infant, and child mortality by cause in provinces of Iran: An analysis for the Global Burden of Disease study 2019
All provinces achieved the Sustainable Development Goal 3.2 of neonatal mortality less than 12 and child mortality less than 25 per 1000 live births. However, disparities still exist across provinces, specifically in low-SDI provinces.
Levels and trends of maternal mortality and morbidity by cause in North Africa and Middle East, 1990 to 2019: An analysis for the Global Burden of Disease study 2019
Maternal mortality has significantly declined in the region since 1990 and only five countries (Afghanistan, Sudan, Yemen, Morocco, and Algeria) out of 21 nations didn’t achieve the Sustainable Development Goal (SDG) target of 70 deaths per 100,000 live births in 2019.
Financing Global Health
Explore patterns of global health financing flows from 1990 to 2050.
Financing Global Health 2021: Global Health Priorities in a Time of Change
For over a decade, this report has provided policy makers with critical information on current and future health financing and spending. The 13th edition, Financing Global Health 2021, expands on, and adds new estimates to, topics like pandemic preparedness, future health spending, and development assistance for health.
Global investments in pandemic preparedness and COVID-19: tracking development assistance and domestic spending on health between 1990 and 2026
We aimed to provide a comparative assessment of global health spending at the onset of the pandemic; characterise the amount of development assistance for pandemic preparedness and response disbursed in the first 2 years of the COVID-19 pandemic; and examine expectations for future health spending and put into context the expected need for investment in pandemic preparedness.
Burden of disease due to amphetamines, cannabis, cocaine, and opioid use disorders in South America, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019
This study investigated the burden of disease attributable to amphetamine use disorder, cannabis use disorder (CAD), cocaine use disorder, and opioid use disorder (OUD) in South America from 1990 to 2019, on the basis of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019.
FGH 2021: COVID-19
Disease spending profile for COVID-19, updated for the latest edition of the Financing Global Health report.
FGH 2021: HIV/AIDS
Disease spending profile for HIV/AIDS, updated for the latest edition of the Financing Global Health report.
FGH 2021: Malaria
Disease spending profile for malaria, updated for the latest edition of the Financing Global Health report.
FGH 2021: Non-communicable diseases
Disease spending profile for non-communicable diseases, updated for the latest edition of the Financing Global Health report.
FGH 2021: Other infectious diseases
Disease spending profile for other infectious diseases, updated for the latest edition of the Financing Global Health report.
FGH 2021: Reproductive, maternal, newborn, and child health
Disease spending profile for reproductive, maternal, newborn, and child health, updated for the latest edition of the Financing Global Health report.
FGH 2021: Tuberculosis
Disease spending profile for tuberculosis, updated for the latest edition of the Financing Global Health report.
The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Comparison of health indicators since 1990 provides valuable insights about Pakistan's ability to strengthen its health-care system, reduce inequalities, improve female and child health outcomes, achieve universal health coverage, and meet the UN Sustainable Development Goals.
Meningococcal A conjugate vaccine coverage in the meningitis belt of Africa from 2010 to 2021: A modelling study
These estimates highlight where gaps in immunization remain and emphasize the need for broader efforts to strengthen routine immunization systems.
The temporal trend of disease burden attributable to metabolic risk factors in China, 1990–2019
The disease burden attributable to metabolic risk factors is rapidly increasing in China, especially in older people.
Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018
These estimates offer epidemiologically informative detail to better guide more targeted interventions, vital for combating HIV in SSA.
COVID-19 Projections
Explore forecasts of demand for hospital services, reported and excess deaths due to COVID-19, rates of infection and testing, and the impact of social distancing and mask use.
Tracking development assistance for health from India to low- and middle-income countries, 2009–2020
India’s DAH allocation strategy prioritizes contributions toward neighboring countries in the South Asia region in several health focus areas.
The global burden of cardiovascular diseases and risk: A compass for future health
The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 and has provided an updated perspective on the status of cardiovascular health globally, regionally, and nationally.
A GBD 2019 study of health and Sustainable Development Goal gains and forecasts to 2030 in Spain
Here, we detail the updated Spain 1990–2019 burden of disease estimates and project certain metrics up to 2030.